BNTC
USDBenitec Biopharma Inc. Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$15.330
Máximo
$15.770
Mínimo
$14.550
Volumen
0.13M
Fundamentos de la Empresa
Capitalización de Mercado
412.4M
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
0.05M
Bolsa
NCM
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
HC Wainwright & Co. Maintains Buy on Benitec Biopharma, Raises Price Target to $35
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Benitec Biopharma with a Buy and raises the price target from $28 to $35.
Citizens Maintains Market Outperform on Benitec Biopharma, Raises Price Target to $22
Citizens analyst Silvan Tuerkcan maintains Benitec Biopharma with a Market Outperform and raises the price target from $20 to $22.
Benitec Biopharma Provides Positive Interim Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial and Receives FDA Fast Track Designation for BB-301
Fast Track Designation was granted for BB-301 following FDA review of positive interim clinical study results and proprietary Responder Analysis planned for use in pivotal study for BB-301 BB-301 has also been granted
Benitec Biopharma Announces Appointment of Sharon Mates Ph.D. to its Board of Directors
HAYWARD, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ:BNTC) ("Benitec" or "Company"), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based
Benitec Biopharma to Provide Phase 1b/2a Clinical Study Update for BB-301 in Oculopharyngeal Muscular Dystrophy
HAYWARD, Calif., Nov. 02, 2025 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ:BNTC) ("Benitec" or the "Company"), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines
Acciones Relacionadas
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.